Clinical Trial Update: Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

View source ↗

Summary

A follow-up gene therapy trial for critical limb ischemia is currently enrolling by invitation, sponsored by Beijing Northland Biotech Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Arteriosclerosis Obliterans
• Critical Limb Ischemia
• Diabetic Foot Ulcer
• Peripheral Arterial Disease
• Thromboangiitis Obliterans

Snippet

Sponsor: Beijing Northland Biotech. Co., Ltd. | Conditions: Peripheral Arterial Disease(PAD), Arterial Occlusive Disease | Status: ENROLLING_BY_INVITATION